Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on New York Business Digest.

Banzai Appoints Matt McCurdy as Vice President of Sales to Drive Strategic Growth of AI-Enabled Marketing and Sales Solutions to Enterprise Customers
SEATTLE, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced the appointment of Matt...

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
Denali’s registration statement on Form S-4 declared effective by the Securities and Exchange Commission Extraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the proposed business combination is scheduled to be...

DPF BOX Launches New York Location, Bringing Fast and Affordable Diesel Filter Cleaning to the East Coast
DPF BOX, a trusted leader in dpf cleaning in Las Vegas, has officially opened location in New York, now accessible to drivers across both coasts. LAS VEGAS, NV, UNITED STATES, August 8, 2025 /EINPresswire.com/ -- DPF BOX, a trusted leader in dpf...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at...

Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q3 2025 $7.0 million royalty monetization agreement signed with Immedica Pharma AB for future ganaxolone royalties, delivering capital...

Materna Health to Open NYC’s First Same-Day/Next-Day Early Pregnancy Care Center
New model aims to keep women out of ERs and close the prenatal care gap from preconception to 24 weeks. NEW YORK, NY, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- This fall, a former CFO of a healthcare-focused investment bank, a...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of National Grid plc - NGG
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of National Grid plc (“National Grid” or the “Company”) (NYSE: NGG). Such investors are advised to contact Danielle Peyton at...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...

2025 New York Photography Awards Now Open for Global Submissions
The International Awards Associate (IAA) officially announces the 2025 New York Photography Awards, now accepting entries from photographers around the world. NEW YORK, NY, UNITED STATES, August 8, 2025 /EINPresswire.com/ -- The International...

ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Funko, Inc. - FNKO
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Funko, Inc. (“Funko” or the “Company”) (NASDAQ: FNKO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BellRing Brands, Inc. – BRBR
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE: BRBR). Such investors are advised to contact Danielle Peyton at...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at...

Immatics Announces Second Quarter 2025 Financial Results and Business Update
Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: One-time infusion continues to show favorable tolerability as well as strong anti-tumor activity and durability in 33 heavily pretreated patients with metastatic melanoma in data from...

Beamr in Q2-2025: Demonstrating the Validation of its Solution for the Autonomous Vehicle Market
Beamr Issues Q2-2025 CEO Letter to Shareholders and Announces its First Half 2025 Financial Results Herzliya, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions,...

Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
– Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with quarterly dosing – — Additional data from the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of WPP plc - WPP
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of WPP plc (“WPP” or the “Company”) (NYSE: WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). Such investors are advised to contact Danielle Peyton at...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at...